COVID-19–induced acute kidney injury in critically ill patients: epidemiology, risk factors, and outcome
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The kidney represents a potential target for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Clinical data about acute kidney injury (AKI) during SARS-CoV-2 infection are lacking. We aimed to investigate the proportion, risk factors, and prognosis of AKI in critical patients affected with SARS-CoV-2. Methods: A case/control study was conducted in two intensive care units of a tertiary teaching hospital. Results: Among 109 patients, 75 were male (69%) with median age at 64 years and 48 (44%) developed AKI within 4 days (interquartile range [IQR], 1–9). Of them, 11 (23%), 9 (19%), and 28 (58%) were classified as stage 1, 2, and 3, respectively. AKI patients were older and presented more sepsis, acute respiratory distress syndrome, and rhabdomyolysis; higher initial urea and creatinine; more marked inflammatory syndrome and hematological disorders; and required more mechanical ventilation and vasopressors. An elevated D-dimers level (odds ratio [OR], 12.83; 95% confidence interval [CI], 1.9–85) was an independent factor of AKI. Sepsis was near to significance (OR, 5.22; 95% CI, 0.94–28; P=0.058). AKI was independently related to mortality (OR, 6.8; 95% CI, 1.49–105) and significantly reduced the survival (14.7 days; IQR, 12-17 vs. 19.9 days; IQR, 17-22.7; P=0.011) in AKI and no AKI group respectively. Hypoxemia with the ratio of the arterial partial pressure of oxygen and the inspiratory concentration of oxygen <70, and vasopressors were identified as mortality factors. Conclusions: AKI occurred in almost half the studied patients and significantly worsened their prognosis. A high D-dimers level and sepsis contributed significantly to its development.
Abstract
Background: The kidney represents a potential target for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Clinical data about acute kidney injury (AKI) during SARS-CoV-2 infection are lacking. We aimed to investigate the proportion, risk factors, and prognosis of AKI in critical patients affected with SARS-CoV-2. Methods: A case/control study was conducted in two intensive care units of a tertiary teaching hospital. Results: Among 109 patients, 75 were male (69%) with median age at 64 years and 48 (44%) developed AKI within 4 days (interquartile range [IQR], 1–9). Of them, 11 (23%), 9 (19%), and 28 (58%) were classified as stage 1, 2, and 3, respectively. AKI patients were older and presented more sepsis, acute respiratory distress syndrome, and rhabdomyolysis; higher initial urea and creatinine; more marked inflammatory syndrome and hematological disorders; and required more mechanical ventilation and vasopressors. An elevated D-dimers level (odds ratio [OR], 12.83; 95% confidence interval [CI], 1.9–85) was an independent factor of AKI. Sepsis was near to significance (OR, 5.22; 95% CI, 0.94–28; P=0.058). AKI was independently related to mortality (OR, 6.8; 95% CI, 1.49–105) and significantly reduced the survival (14.7 days; IQR, 12-17 vs. 19.9 days; IQR, 17-22.7; P=0.011) in AKI and no AKI group respectively. Hypoxemia with the ratio of the arterial partial pressure of oxygen and the inspiratory concentration of oxygen <70, and vasopressors were identified as mortality factors. Conclusions: AKI occurred in almost half the studied patients and significantly worsened their prognosis. A high D-dimers level and sepsis contributed significantly to its development.
참고문헌 (29)
- White-Dzuro G, "Multisystem effects of COVID-19 : a concise review for practitioners", Postgrad Med, 133, pp.20~27 (2021)
- Grasselli G, "Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy", JAMA, 323, pp.1574~1581 (2020)
- Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China", N Engl J Med, 382, pp.1708~1720 (2020)
- Richardson S, "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area", JAMA, 323, pp.2052~2059 (2020)
- Xie J, "Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease(COVID-19)in China : a retrospective multicenter study", Intensive Care Med, 46, pp.1863~1872 (2020)
- Gheblawi M, "Angiotensin-converting enzyme 2 : SARS-CoV-2 receptor and regulator of the renin-angiotensin system : celebrating the 20th anniversary of the discovery of ACE2", Circ Res, 126, pp.1456~1474 (2020)
- Diao B, "Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection", Nat Commun, 12, pp.2506~ (2021)
- Arentz M, "Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state", JAMA, 323, pp.1612~1614 (2020)
- Yang X, "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study", Lancet Respir Med, 8, pp.475~481 (2020)
- Sang L, "The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study", BMC Pulm Med, 20, pp.290~ (2020)
- Cheng Y, "Kidney disease is associated with in-hospital death of patients with COVID-19", Kidney Int, 97, pp.829~838 (2020)
- Singer M, "The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)", JAMA, 315, pp.801~810 (2016)
- Palevsky PM, "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury", Am J Kidney Dis, 61, pp.649~672 (2013)
- De Rosa S, "Creatinine-based definitions : from baseline creatinine to serum creatinine adjustment in in tensive care", Crit Care, 20, pp.69~ (2016)
- Bouchard J, "Estimating baseline serum creatinine for assessing acute kidney injury : not a one size fits all approach", Kidney Int Rep, 6, pp.562~564 (2021)
- Chawla LS, "Acute kidney disease and renal recovery : consensus report of the Acute Disease Quality Initiative(ADQI)16 Workgroup", Nat Rev Nephrol, 13, pp.241~257 (2017)
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
- Panitchote A, "Factors associated with acute kidney injury in acute respiratory distress syndrome", Ann Intensive Care, 9, pp.74~ (2019)
- Nin N, "Acute kidney injury in critically ill patients with 2009 influenza A(H1N1)viral pneumonia : an observational study", Intensive Care Med, 37, pp.768~774 (2011)
- Darmon M, "Acute respiratory distress syndrome and risk of AKI among critically ill patients", Clin J Am Soc Nephrol, 9, pp.1347~1353 (2014)
- Chueh TI, "Novel evidence of acute kidney injury in COVID-19", J Clin Med, 9, pp.3547~ (2020)
- Jhaveri KD, "Thrombotic microangiopathy in a patient with COVID-19", Kidney Int, 98, pp.509~512 (2020)
- Fuhrman DY, "Acute kidney injury epidemiology, risk factors, and outcomes in critically ill patients 16-25 years of age treated in an adult intensive care unit", Ann Intensive Care, 8, pp.26~ (2018)
- Zarbock A, "Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies", Curr Opin Crit Care, 20, pp.588~595 (2014)
- Monteil V, "Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2", Cell, 181, pp.905~913 (2020)
- Palazzuoli A, "Antecedent administration of angiotensin-converting enzyme inhibitors or angiotensin ii receptor antagonists and survival after hospitalization for COVID-19 syndrome", J Am Heart Assoc, 9, pp.e017364~ (2020)
- Lombardi R, "Acute kidney injury in mechanically ventilated patients : the risk factor profile depends on the timing of AKI onset", Shock, 48, pp.411~417 (2017)
- Ranieri VM, "Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome", JAMA, 284, pp.43~44 (2000)
- Kuiper JW, "Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship?", Crit Care, 15, pp.228~ (2011)